Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights
  • Choose License Type

Global Automated Patch Clamp System Market, By Technique (Automated Glass Pipette-based Patch Clamp, Micro-fabricated Planar Electrode-based Patch Clamp, and Automated TEVC On Xenopus Oocytes), By Amplifiers (8, 16, 384, 768, and Others), By End User (Contract Research Organization, Biopharmaceuticals, and Academic & Research Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 412.01 million in 2020 and is expected to exhibit a CAGR of 6.9% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

The companies are focusing on technological advancements in automated patch clamp systems, in order to expand their product portfolio and strengthen their presence in the market, which is expected to drive growth of the automated patch clamp system market over the forecast period. For instance, in February 2017, Nanion Technologies GmbH announced that Genedata, a provider of advanced software solutions for drug discovery and life science research, developed new automated patch clamp (APC) functionality in Genedata Screener for Ion Channel Screening and a Genedata Ready-to-Run integration with Nanion SyncroPatch 384PE, an automated patch clamp system manufactured by Nanion Technologies GmbH.

Global Automated Patch Clamp System Market – Impact of Coronavirus (Covid-19) Pandemic

Several countries across the world have been observing lockdowns due to the dynamically increasing cases of COVID-19. The research institutes have also been closed during the pandemic in order to control the spread of COVID-19 infection, which has impacted the drug development process significantly. According to an article published in the Lancet in August 2020, thousands of clinical trials have been suspended or stopped due to difficulties in continuing under lockdown conditions. Moreover, in May 2020, WCG CenterWatch, a pioneer in publishing clinical trials information, informed that 44% of more than 2,600 clinical trials have been halted in the past five months due to COVID-19.

Browse 35 Market Data Tables and 34 Figures spread through 198 Pages and in-depth TOC on “Automated Patch Clamp System Market- By Technique (Automated Glass Pipette-based Patch Clamp, Micro-fabricated Planar Electrode-based Patch Clamp, and Automated TEVC On Xenopus Oocytes), By Amplifiers (8, 16, 384, 768, and Others), By End User (Contract Research Organization, Biopharmaceuticals, and Academic & Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027”

To know the latest trends and insights prevalent in the global automated patch clamp system market, click the link below:

https://www.coherentmarketinsights.com/market-insight/automated-patch-clamp-system-market-4307

Increasing demand for automated patch clamp system is expected to propel growth of global automated patch clamp system market. For instance, in February 2015, Cardiac Researchers at National Heart Centre, Singapore acquired the SyncroPatch 384/768PE, an automated patch clamp system provided by Nanion Technologies GmbH to investigate the effects of chemical compounds and toxins on ion channel function.

Key Takeaways of the Global Automated Patch Clamp System Market:

  • The global automated patch clamp system market is expected to exhibit a CAGR of 6.9% over the forecast period, owing to increasing launches of new automated patch clamp systems by market players. For instance, in November 2016, Fluxion Biosciences launched the second generation of its IonFlux automated patch clamp family of products, IonFlux Mercury, which replaced the existing IonFlux automated patch clamp system.
  • Among technique, the micro-fabricated planar electrode-based patch clamp segment held a dominant position in the automated patch clamp system market in 2019, owing to increasing agreements for automated patch clamps by market players. For instance, in July 2016, Icagen Inc. entered into an agreement with Nanion Technologies GmbH to develop and commercialize innovative ion channel drug discovery solutions for SyncroPatch384 High-Throughput Electrophysiology Platform.
  • Key players operating in the global automated patch clamp system market include Sophion Bioscience A/S, Nanion Technologies GmbH, NeoBiosystems, Inc., Multi Channel Systems MCS GmbH, Fluxion Biosciences, Molecular Devices, LLC, Scitech Korea Inc., and HEKA Elektronik GmbH
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner